NCT01395420View on ClinicalTrials.gov

Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Healthy
Interventions
DRUG

CAZ104

IV Infusion

DRUG

CAZ104

IV Infusion

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01395420 - Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma | Biotech Hunter | Biotech Hunter